SEC Form 5 · accession 0001185185-18-000845
IGC Pharma, Inc. · IGC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard K Prins
Director
Period of report
Mar 31, 2018
Accepted (ET)
May 10, 2018 · 8:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326205
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Dec 6, 2017 | G | 2,000 | $0.00 | D | 394,000 | D | |
| Common stock | Dec 8, 2017 | G | 3,000 | $0.00 | D | 391,000 | D | |
| Common stock | Dec 11, 2017 | G | 20,000 | $0.00 | D | 371,000 | D | |
| Common stock | Dec 14, 2017 | G | 20,000 | $0.00 | D | 351,000 | D | |
| Common stock | Dec 15, 2017 | G | 3,000 | $0.00 | D | 348,000 | D | |
| Common stock | Dec 22, 2017 | G | 3,000 | $0.00 | D | 345,000 | D | |
| Common stock | Dec 28, 2017 | G | 20,000 | $0.00 | D | 325,000 | D | |
| Common stock | Dec 29, 2017 | G | 3,000 | $0.00 | D | 322,000 | D | |
| Common stock | Jan 5, 2018 | G | 3,000 | $0.00 | D | 319,000 | D | |
| Common stock | Jan 12, 2018 | G | 3,000 | $0.00 | D | 316,000 | D | |
| Common stock | Jan 19, 2018 | G | 3,000 | $0.00 | D | 313,000 | D | |
| Common stock | Jan 26, 2018 | G | 3,000 | $0.00 | D | 310,000 | D | |
| Common stock | Feb 2, 2018 | G | 3,000 | $0.00 | D | 307,000 | D | |
| Common stock | Feb 9, 2018 | G | 3,000 | $0.00 | D | 304,000 | D | |
| Common stock | Feb 16, 2018 | G | 3,000 | $0.00 | D | 301,000 | D | |
| Common stock | Feb 23, 2018 | G | 3,000 | $0.00 | D | 298,000 | D | |
| Common stock | Mar 2, 2018 | G | 3,000 | $0.00 | D | 295,000 | D | |
| Common stock | Mar 9, 2018 | G | 3,000 | $0.00 | D | 292,000 | D | |
| Common stock | Mar 16, 2018 | G | 3,000 | $0.00 | D | 289,000 | D | |
| Common stock | Mar 23, 2018 | G | 3,000 | $0.00 | D | 286,000 | D | |
| Common stock | Mar 29, 2018 | G | 3,000 | $0.00 | D | 283,000 | D | |
| Common stock | Apr 6, 2018 | G | 3,000 | $0.00 | D | 280,000 | D | |
| Common stock | Apr 13, 2018 | G | 3,000 | $0.00 | D | 277,000 | D | |
| Common stock | Apr 20, 2018 | G | 3,000 | $0.00 | D | 274,000 | D | |
| Common stock | Apr 27, 2018 | G | 3,000 | $0.00 | D | 271,000 | D | |
| Common stock | May 4, 2018 | G | 3,000 | $0.00 | D | 268,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
THIS FORM 5 IS A CONTINUATION OF THE FORM 5 FILE IMMEDIATELY PRIOR. THE FILINGS WERE SEPARATED DUE TO INSUFFICIENT ROOM ON THE FIRST FILING TO SUPPLY ALL OF THE DATA.